|
TTC33 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64335212105016E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66999747364116E-12 |
| Normal-vs-Stage2 |
2.51480000001969E-06 |
| Normal-vs-Stage3 |
3.61650043245731E-10 |
| Normal-vs-Stage4 |
4.95989915805239E-11 |
| Stage1-vs-Stage2 |
6.864800E-01 |
| Stage1-vs-Stage3 |
4.578800E-01 |
| Stage1-vs-Stage4 |
2.549800E-02 |
| Stage2-vs-Stage3 |
4.097000E-01 |
| Stage2-vs-Stage4 |
4.042100E-02 |
| Stage3-vs-Stage4 |
1.477830E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.37427871702312E-14 |
| Normal-vs-AfricanAmerican |
6.226000E-04 |
| Normal-vs-Asian |
7.31570000134241E-08 |
| Caucasian-vs-AfricanAmerican |
3.021000E-01 |
| Caucasian-vs-Asian |
9.830200E-01 |
| AfricanAmerican-vs-Asian |
3.603400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.03119957017839E-10 |
| Normal-vs-Female |
1.74726899615507E-12 |
| Male-vs-Female |
9.632800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.96990004705822E-10 |
| Normal-vs-Age(41-60Yrs) |
3.3717473257866E-12 |
| Normal-vs-Age(61-80Yrs) |
2.53229992530635E-10 |
| Normal-vs-Age(81-100Yrs) |
6.763800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.489200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.517790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.807600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.618200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.184800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.144600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.611000E-04 |
| Classical-VS-Follicular |
3.903200E-01 |
| Classical-VS-Other |
6.285800E-01 |
| Classical-VS-Normal |
4.49099646360196E-11 |
| Tall-VS-Follicular |
1.264200E-02 |
| Tall-VS-Other |
2.594800E-01 |
| Tall-VS-Normal |
2.41540121237449E-11 |
| Follicular-VS-Other |
8.424800E-01 |
| Follicular-VS-Normal |
3.3375999741736E-09 |
| Other-VS-Normal |
8.336900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.18072218668885E-12 |
| Normal-vs-N1 |
7.80370001951525E-09 |
| N0-vs-N1 |
6.470600E-01 |
|
|
